You have 9 free searches left this month | for more free features.

Coagulants

Showing 1 - 25 of 92

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in

Active, not recruiting
  • Pleural Effusion
  • Thoracic Effusion
  • Novel Oral Anti-Coagulants
  • New Haven, Connecticut
    Yale New Haven Hospital
Oct 10, 2022

Oral Anticoagulants in Non-valvular Atrial Fibrillation

Active, not recruiting
  • Non-Valvular Atrial Fibrillation
    • Ann Arbor, Michigan
      Local Institution
    Jan 26, 2022

    Oral Anti-coagulants in Fragile Percutaneous Endoscopic

    Completed
    • Atrial Fibrillation
    • Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Oct 25, 2021

    Association Between Genetic Variant Scores and DOACs (DARES2)

    Recruiting
    • Drug-Related Side Effects and Adverse Reactions
    • Iatrogenic Disorder
      • Seongnam-si, Gyonggi-do, Korea, Republic of
        SNUBH
      Jul 18, 2022

      Severe Hemophilia A Subjects Who Received BMN 270 inPrior

      Enrolling by invitation
      • Hemophilia A
        • London, United Kingdom
          Royal London Hospital, Barts and the London Hemophilia Center
        Mar 13, 2023

        Hemophilia A, Gene Therapy, Clotting Disorders Trial in Johannesburg, London, Southampton (Valoctocogene Roxaparvovec)

        Recruiting
        • Hemophilia A
        • +3 more
        • Valoctocogene Roxaparvovec
        • Seoul, Korea, Republic of
        • +8 more
        Jan 6, 2023

        Method Optimization for the Quantification of the NAD

        Completed
        • NAD
        • Laboratory method validation
        • Lausanne, Switzerland
          Clinical Innovation Lab.
        Sep 27, 2022

        Hemophilia A With Inhibitor, Hemophilia A With Anti Factor VIII Trial in United Kingdom, United States (Valoctocogene

        Recruiting
        • Hemophilia A With Inhibitor
        • Hemophilia A With Anti Factor VIII
        • Valoctocogene roxaparvovec
        • Los Angeles, California
        • +4 more
        Aug 2, 2022

        Alveolar Ridge Enlargement Trial in Cairo (Alveolar ridge augmentation with injectable platelets rich fibrin, Alveolar ridge

        Completed
        • Alveolar Ridge Enlargement
        • Alveolar ridge augmentation with injectable platelets rich fibrin
        • +2 more
        • Cairo, Abbassia, Egypt
        • +1 more
        Mar 12, 2023

        Hemophilia A Trial in Atlanta (aPCC-emicizumab, FEIBA, rFVIIa)

        Not yet recruiting
        • Hemophilia A
        • Atlanta, Georgia
        • +1 more
        Jan 5, 2023

        Thromboelastography and Conventional Coagulation Tests in

        Not yet recruiting
        • Thromboelastography
        • +2 more
        • thromboelastography
        • (no location specified)
        Mar 30, 2023

        Severe Haemophilia A Trial in United Kingdom (valoctocogene roxaparvovec)

        Active, not recruiting
        • Severe Haemophilia A
        • valoctocogene roxaparvovec
        • Basingstoke, United Kingdom
        • +5 more
        Feb 22, 2022

        Direct Oral Anticoagulants for the Treatment of Mural Thrombus

        Completed
        • Acute Myocardial Infarction
          • Dallas, Texas
            Methodist Dallas Medical Center
          Dec 9, 2021

          Hemophilia A Trial in Worldwide (valoctocogene roxaparvovec)

          Active, not recruiting
          • Hemophilia A
          • valoctocogene roxaparvovec
          • Los Angeles, California
          • +47 more
          Dec 21, 2022

          Hemophilia A Trial in Worldwide (valoctocogene roxaparvovec)

          Active, not recruiting
          • Hemophilia A
          • valoctocogene roxaparvovec
          • Saint Louis, Missouri
          • +10 more
          Feb 25, 2022

          G6PD Deficiency Trial in Reading (SD Biosensor STANDARD G6PD Test, Pointe Scientific Test Kit, HemoCue System)

          Completed
          • G6PD Deficiency
          • SD Biosensor STANDARD G6PD Test
          • +2 more
          • Reading, Pennsylvania
            BSC corporation
          Oct 15, 2021

          Sacubitril/Valsartan in Heart Failure With Reduced Ejection

          Completed
          • Heart Failure
          • Mumbai, India
            Novartis Investigational Site
          Sep 20, 2022

          Coronary Artery Ectasia Trial (Rivaroxaban 2.5 Mg Oral Tablet twice daily, Clopidogrel 75 Mg Oral Tablet, Aspirin tablet 75 mg)

          Not yet recruiting
          • Coronary Artery Ectasia
          • Rivaroxaban 2.5 Mg Oral Tablet twice daily
          • +2 more
          • (no location specified)
          Jan 30, 2023

          Pregnancy and Relation to Pregnancy Outcome

          Completed
          • Fetal Growth Retardation
          • Naser Al-Husban
          • (no location specified)
          Dec 28, 2021

          Safety Outcome in Atrial Fibrillation Treated by Apixaban in

          Recruiting
          • Atrial Fibrillation
            • Brussels, Belgium
              Pfizer Site
            Oct 10, 2022

            Pneumonia, Viral Trial in Asyut (steroid and anticoagulants according to different protocols.)

            Completed
            • Pneumonia, Viral
            • steroid and anticoagulants according to different protocols.
            • Asyut, Egypt
              Marwarady
            Aug 23, 2021

            Immune Response in Hypersensitivity Pneumonitis

            Completed
            • Hypersensitivity Pneumonitis
            • Bronchoscopy with lavage
            • Iowa City, Iowa
              University of Iowa
            May 16, 2022

            Breast Cancer Female, Breast Cancer Stage I, Breast Cancer Stage II Trial (Mindfulness-Based Cognitive Therapy (MBCT-Ca) -

            Recruiting
            • Breast Cancer Female
            • +3 more
            • Mindfulness-Based Cognitive Therapy (MBCT-Ca) - online
            • +2 more
            • Brno, Bohunice, Czechia
              Faculty of Medicine, Masaryk University
            Sep 15, 2022

            COVID-19 Trial in Rawalpindi (Apixaban, Rivaroxaban)

            Not yet recruiting
            • COVID-19
            • Rawalpindi, Punjab, Pakistan
              Rawalpindi Medical University
            Feb 22, 2022